Related references
Note: Only part of the references are listed.Classics in Chemical Neuroscience: Chlorpromazine
Debra Boyd-Kimball et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
Maximilian Huhn et al.
LANCET (2019)
A quantum chemical approach representing a new perspective concerning agonist and antagonist drugs in the context of schizophrenia and Parkinson's disease
Ana Martinez et al.
PLOS ONE (2019)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
Simon D. Harding et al.
NUCLEIC ACIDS RESEARCH (2018)
Classics in Chemical Neuroscience: Risperidone
Trevor C. Chopko et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Current Concepts and Treatments of Schizophrenia
Piotr Stepnicki et al.
MOLECULES (2018)
UniProt: the universal protein knowledgebase
Alex Bateman et al.
NUCLEIC ACIDS RESEARCH (2017)
Challenges and opportunities for the development of new antipsychotic drugs
Carlos Forray et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Classics in Chemical Neuroscience: Haloperidol
Marshall W. Tyler et al.
ACS CHEMICAL NEUROSCIENCE (2017)
PubChem Substance and Compound databases
Sunghwan Kim et al.
NUCLEIC ACIDS RESEARCH (2016)
Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future
Peng Li et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
Evaluating the dopamine hypothesis of schizophrenia in a large-scale genome-wide association study
Alexis C. Edwards et al.
SCHIZOPHRENIA RESEARCH (2016)
Clozapine, a Fast-Off-D2 Antipsychotic
Philip Seeman
ACS CHEMICAL NEUROSCIENCE (2014)
Evaluation of the antiradical activity of hyperjovinol-A utilizing donor-acceptor maps
Rogelio A. Delgado Alfaro et al.
JOURNAL OF MOLECULAR MODELING (2014)
Classics in Chemical Neuroscience: Clozapine
Cody J. Wenthur et al.
ACS CHEMICAL NEUROSCIENCE (2013)
Neurochemistry of Schizophrenia: The Contribution of Neuroimaging Postmortem Pathology and Neurochemistry in Schizophrenia
B. Dean
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
A Theoretical Study of the Reaction of β-Carotene with the Nitrogen Dioxide Radical in Solution
J. P. Ceron-Carrasco et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2010)
Donator Acceptor Map of Psittacofulvins and Anthocyanins: Are They Good Antioxidant Substances?
Ana Martinez
JOURNAL OF PHYSICAL CHEMISTRY B (2009)
Universal Solvation Model Based on Solute Electron Density and on a Continuum Model of the Solvent Defined by the Bulk Dielectric Constant and Atomic Surface Tensions
Aleksandr V. Marenich et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2009)
A multi-etiology model of systemic degeneration in schizophrenia
Anca Radulescu
JOURNAL OF THEORETICAL BIOLOGY (2009)
Emerging opportunities for antipsychotic drug discovery in the postgenomic era
Michael J. Marino et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Donator acceptor map for carotenoids, melatonin and vitamins
Ana Martinez et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2008)
Electrodonating and electroaccepting powers
Jose L. Gazquez et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2007)
Lifetime prevalence of psychotic and bipolar I disorders in a general population
Jonna Perala et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia
Jiri Horacek et al.
CNS DRUGS (2006)
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
S Miyamoto et al.
MOLECULAR PSYCHIATRY (2005)
Schizophrenia: Etiology and course
E Walker et al.
ANNUAL REVIEW OF PSYCHOLOGY (2004)
Novel mechanisms of drug action: Functional selectivity at D-2 dopamine receptors (A lesson for drug discovery)
RB Mailman et al.
MEDICINAL CHEMISTRY RESEARCH (2004)
Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder
SG Potkin et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors
KD Burris et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics?:: A new hypothesis
S Kapur et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis
J Geddes et al.
BRITISH MEDICAL JOURNAL (2000)
Share Paper
